Search results
Professor Bradley Turner is Head of the Motor Neuron Disease Group and Research Lead of the Brain Health and Repair Mission. His group has a broad research interest in neurodegenerative diseases affecting the voluntary motor system in the brain and spinal cord.
Founded in 1943, the Bradley-Turner Foundation strives to carry out, in perpetuity, the charitable legacy of its founders by making grants to enhance the quality of life in Columbus, Georgia, its region, and throughout Georgia and elsewhere in the United States, as resources permit.
Florey Institute of Neuroscience & Mental Health - 17.240-mal zitiert - ALS MND SBMA Neurodegeneration
Metabolic Dysfunction in Motor Neuron Disease: Shedding Light through the Lens of Autophagy. Subhavi De Silva, Bradley J Turner, Nirma D Perera. Journal article | 2022 | METABOLITES. Amyotrophic lateral sclerosis (ALS) patients show a myriad of energetic abnormalities, such as weight loss, hypermetabolism, and d..
Project: TARGETING THE METABOLISM OF GLYCOSPHINGOLIPIDS AS A NOVEL THERAPEUTIC STRATEGY FOR MND. MND is a complex and multifactorial disorder. There is increasing evidence that abnormal energy and lipid metabolism within nerve cells and muscles contributes to the disease course and underlying motor neuron pathology.
Dr. Bradley Turner, a researcher at the University of Melbourne's Howard Florey Institute, has been awarded for his inspiring work to stop motor neurone disease.
Phyllis has been a part of the Bradley-Turner Foundation for over 25 years. She was the administrator under Bill Turner and Tom Black, and she has overseen over $150 million in grants since her arrival.
